Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trials.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2010

Same author

Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumors.

Oncogene·2006

Same author

Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer.

Bone marrow transplantation·2003

Same author

Peritoneal mesothelioma.

Current treatment options in oncology·2002

Same author

New biology and therapies in soft tissue sarcomas.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2002

Same author

Overview of the six available randomized trials of high-dose chemotherapy with blood or marrow transplant in breast cancer.

Journal of the National Cancer Institute. Monographs·2002

Search research articles

Related Experiment Video

Updated: Jul 27, 2026

Electrochemotherapy of Tumours

Electrochemotherapy of Tumours

Published on: December 15, 2008

Chemotherapy for malignant mesothelioma

R N Taub¹, K H Antman

¹Department of Medicine, Columbia University College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, New York, NY 10032, USA.

Seminars in Thoracic and Cardiovascular Surgery

|November 14, 1997

Summary

Treating malignant mesothelioma (MM) is difficult due to study limitations. Current chemotherapy regimens show modest activity, with ongoing research into new treatments and drug delivery methods.

More Related Videos

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Related Experiment Videos

Last Updated: Jul 27, 2026

Electrochemotherapy of Tumours

Electrochemotherapy of Tumours

Published on: December 15, 2008

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Area of Science:

Oncology
Thoracic Surgery

Background:

Malignant mesothelioma (MM) treatment presents significant challenges.
Publication bias and difficulties in response assessment complicate research.
The natural history of MM is variable, with a generally short duration.

Purpose of the Study:

To review the current state of malignant mesothelioma treatment.
To highlight challenges in clinical trial design and interpretation.
To discuss the efficacy of existing chemotherapeutic agents and future research directions.

Main Methods:

Review of existing literature and clinical trial data.
Analysis of response rates and survival data from cooperative group studies.
Discussion of challenges in assessing tumor response due to pleural tumor distribution.

Main Results:

Doxorubicin, cisplatin, and ifosfamide demonstrate modest activity in MM treatment.
A Cancer and Leukemia Group B study reported a 24% response rate for cisplatin-based regimens.
Survival outcomes were slightly better with doxorubicin-containing combinations.

Conclusions:

Chemotherapy offers modest benefits for malignant mesothelioma patients.
Larger cooperative group studies are improving data reliability.
Ongoing research focuses on novel agents and drug delivery systems for MM.